Related references
Note: Only part of the references are listed.Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer
Alessandra Cavaliere et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Imaging Sigma-1 Receptor (S1R) Expression Using Iodine-124-Labeled 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine ([124I]IPAG)
Kishore K. Gangangari et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Noninvasive PET Imaging of CDK4/6 Activation in Breast Cancer
Nicholas Ramos et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer
Manoj Kumar et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR
Conrad Chan et al.
NUCLEAR MEDICINE AND BIOLOGY (2020)
Preparation and evaluation of 99mTc-labeled HYNIC-palbociclib analogs for cyclin-dependent kinase 4/6-positive tumor imaging
Qianqian Gan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer
Lucia Baratto et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Evaluation of an Integrin αvβ3 and Aminopeptidase N Dual-Receptor Targeting Tracer for Breast Cancer Imaging
Yongkang Gai et al.
MOLECULAR PHARMACEUTICS (2020)
Dual-Receptor-Targeted (DRT) Radiation Nanomedicine Labeled with 177Lu Is More Potent for Killing Human Breast Cancer Cells That Coexpress HER2 and EGFR Than Single-Receptor-Targeted (SRT) Radiation Nanomedicines
Simmyung Yook et al.
MOLECULAR PHARMACEUTICS (2020)
Synthesis and Characterization of Folic Acid Conjugated Gemcitabine Tethered Silver Nanoparticles (FA-GEM-AgNPs) for Targeted Delivery
Arjunan Karuppaiah et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells
Min Jung Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Novel nano-pomegranates based on astragalus polysaccharides for targeting ERα-positive breast cancer and multidrug resistance
Bingjie Wang et al.
DRUG DELIVERY (2020)
Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics
Pardeep Kumar et al.
MOLECULAR IMAGING AND BIOLOGY (2019)
Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer
Farhan S. Cyprian et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases
Barbara Frigerio et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
A. Bardia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
PET imaging of HER2 expression with an 18F-fluoride labeled aptamer
Hyun Jeong Kim et al.
PLOS ONE (2019)
HYNIC and DOMA conjugated radiolabeled bombesin analogs as receptor-targeted probes for scintigraphic detection of breast tumor
Kakali De et al.
EJNMMI RESEARCH (2019)
G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment
Yool Lee et al.
PLOS BIOLOGY (2019)
Chemerin and Cancer
Oliver Treeck et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with 99mTc(I) Tricarbonyl Complex
Anthony Ku et al.
MOLECULAR PHARMACEUTICS (2019)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment
Russell K. Pachynski et al.
FRONTIERS IN IMMUNOLOGY (2019)
Synthesis and Biological Evaluation of Novel 99mTc-Labeled Palbociclib Derivatives Targeting Cyclin-Dependent Kinase 4/6 (CDK4/6) as Potential Cancer Imaging Agents
Xiaoqing Song et al.
MOLECULAR PHARMACEUTICS (2019)
Synthesis and Evaluation of 177Lu-DOTA-DN(PTX)-BN for Selective and Concomitant Radio and Drug-Therapeutic Effect on Breast Cancer Cells
Brenda Gibbens-Bandala et al.
POLYMERS (2019)
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma
Irene M. Ghobrial et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
11C-Labeled Pictilisib (GDC-0941) as a Molecular Tracer Targeting Phosphatidylinositol 3-Kinase (PI3K) for Breast Cancer Imaging
Na Han et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2019)
Preclinical Evaluation of a Fluorine-18 (18F)-Labeled Phosphatidylinositol 3-Kinase Inhibitor for Breast Cancer Imaging
Bouhari Altine et al.
MOLECULAR PHARMACEUTICS (2019)
Development and evaluation of a 99mTc(V)-nitrido complex derived from estradiol for breast cancer imaging
Emilia Tejeria et al.
APPLIED RADIATION AND ISOTOPES (2019)
Integrating molecular nuclear imaging in clinical research to improve anticancer therapy
Elisabeth G. E. de Vries et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
177Lu-Bombesin-PLGA (paclitaxel): A targeted controlled-release nanomedicine for bimodal therapy of breast cancer
Brenda Gibbens-Bandala et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
Agnieszka Morgenroth et al.
BREAST CANCER RESEARCH (2019)
Auger electrons for cancer therapy - a review
Anthony Ku et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)
CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer
Sarah Erdmann et al.
THERANOSTICS (2019)
The emerging role of CDK4/6i in HER2-positive breast cancer
Ciara C. O'Sullivan et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Noninvasive 89Zr-Transferrin PET Shows Improved Tumor Targeting Compared with 18F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer
Kelly E. Henry et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1
Christina M. Maher et al.
MOLECULAR CANCER RESEARCH (2018)
Recent insights into biological functions of mammalian bombesin-like peptides and their receptors
Xiangping Qu et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2018)
Appraising the entourage effect: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Sandra Blasco-Benito et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Bispecific antibody based therapeutics: Strengths and challenges
Archana Thakur et al.
BLOOD REVIEWS (2018)
Breast cancer lung metastasis: Molecular biology and therapeutic implications
Liting Jin et al.
CANCER BIOLOGY & THERAPY (2018)
Development of a novel 99mTc-labeled small molecular antagonist for CXCR4 positive tumor imaging
Xuran Zhang et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2018)
Dual-Targeted Molecular Imaging of Cancer
Emily B. Ehlerding et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
What about αvβ3 integrins in molecular imaging in oncology?
Frederic Debordeaux et al.
NUCLEAR MEDICINE AND BIOLOGY (2018)
Nimotuzumab: beyond the EGFR signaling cascade inhibition
Zaima Mazorra et al.
SEMINARS IN ONCOLOGY (2018)
Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
Amit Kumar Singh et al.
NUTRIENTS (2018)
A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE (R)) antibody construct, in patients with refractory solid tumors
Maxim Kebenko et al.
ONCOIMMUNOLOGY (2018)
Targeting HER2 in Nuclear Medicine for Imaging and Therapy
Adriana V. F. Massicano et al.
MOLECULAR IMAGING (2018)
CXCR4-directed theranostics in oncology and inflammation
Malte Kircher et al.
ANNALS OF NUCLEAR MEDICINE (2018)
Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies
Ming Yuan He et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
HER kinase inhibition in patients with HER2-and HER3-mutant cancers
David M. Hyman et al.
NATURE (2018)
Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y1)- and GRP-Receptors-An Improvement for Breast Cancer Imaging?
Alicia Vall-Sagarra et al.
PHARMACEUTICALS (2018)
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer
Patrick Schoffski et al.
BREAST CANCER RESEARCH (2018)
MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer
Takahiro Maeda et al.
CANCER RESEARCH (2018)
Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer
Jason. P. W. Carey et al.
CANCER RESEARCH (2018)
RNA interference-based therapy and its delivery systems
Xiuhui Chen et al.
CANCER AND METASTASIS REVIEWS (2018)
An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer
Mei Liu et al.
THERANOSTICS (2018)
A Novel Platinum(II)-Based Bifunctional ADC Linker Benchmarked Using 89Zr-Desferal and Auristatin F-Conjugated Trastuzumab
Niels J. Sijbrandi et al.
CANCER RESEARCH (2017)
Phase Ia/Ib study of the pan-class I PI3K inhibitor pictilisib (GDC-0941) administered as a single agent in Japanese patients with solid tumors and in combination in Japanese patients with non-squamous non-small cell lung cancer
Noboru Yamamoto et al.
INVESTIGATIONAL NEW DRUGS (2017)
Combine and conquer: challenges for targeted therapy combinations in early phase trials
Juanita S. Lopez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Progress in nonviral gene therapy for breast cancer and what comes next?
Giulia Bottai et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study
Ravi Salgia et al.
INVESTIGATIONAL NEW DRUGS (2017)
Targeted radionuclide therapy in combined-modality regimens
Martin R. Gill et al.
LANCET ONCOLOGY (2017)
Binding of circulating anti-MUC1 antibody and serum MUC1 antigen in stage IV breast cancer
Yan Tang et al.
MOLECULAR MEDICINE REPORTS (2017)
64Cu-Labeled Trastuzumab Fab-PEG24-EGF Radioimmunoconjugates Bispecific for HER2 and EGFR: Pharmacokinetics, Biodistribution, and Tumor Imaging by PET in Comparison to Monospecific Agents
Luke Yongkyu Kwon et al.
MOLECULAR PHARMACEUTICS (2017)
MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications
Lluis Pascual et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03)
Todd M. Cooper et al.
PEDIATRIC BLOOD & CANCER (2017)
The role of MDM2 and MDM4 in breast cancer development and prevention
Sue Haupt et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2017)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
Fluorescent, Plasmonic, and Radiotherapeutic Properties of the 177Lu-Dendrimer-AuNP-Folate-Bombesin Nanoprobe Located Inside Cancer Cells
Hector Mendoza-Nava et al.
MOLECULAR IMAGING (2017)
89Zr-Cobalamin PET Tracer: Synthesis, Cellular Uptake, and Use for Tumor Imaging
Akhila N. W. Kuda-Wedagedara et al.
ACS OMEGA (2017)
Imaging, biodistribution and in vitro study of smart 99mTc-PAMAM G4 dendrimer as novel nano-complex
Asghar Narmani et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases
Mariz Kasoha et al.
CLINICAL & EXPERIMENTAL METASTASIS (2017)
Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer
Sangeetha Perumalsamy et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation
Kyung-Min Lee et al.
CELL METABOLISM (2017)
The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer
Weigang Wang et al.
CLINICA CHIMICA ACTA (2017)
Targeted therapies in breast cancer: New challenges to fight against resistance
Viviana Masoud et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2017)
Mouse Double Minute 2 Actively Suppresses p53 Activity in Oocytes during Mouse Folliculogenesis
Chen-Xi Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Imaging CXCR4 Expression with 99mTc-Radiolabeled Small-Interference RNA in Experimental Human Breast Cancer Xenografts
Peng Fu et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Synthesis and evaluation of Lys1(α,γ-Folate)Lys3(177Lu-DOTA)-Bombesin(1-14) as a potential theranostic radiopharmaceutical for breast cancer
Liliana Aranda-Lara et al.
APPLIED RADIATION AND ISOTOPES (2016)
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-na⟨ve advanced breast cancer
Stephen Johnston et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2-overexpressing metastatic breast cancer
Hirofumi Mukai et al.
CANCER SCIENCE (2016)
Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas
Michael Pishvaian et al.
CLINICAL COLORECTAL CANCER (2016)
Creating chemotherapeutic-resistant breast cancer cell lines: advances and future perspectives
Catherine E. Steding
FUTURE ONCOLOGY (2016)
Applying 89Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins
Michael G. Doran et al.
MOLECULAR PHARMACEUTICS (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation
Xiaotian Xia et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+Breast Cancer Tumors in the Brain: an In-Vivo Study
Mohamed Ismail Nounou et al.
PHARMACEUTICAL RESEARCH (2016)
CEA in breast ductal secretions as a promising biomarker for the diagnosis of breast cancer: a systematic review and meta-analysis
Shifu Tang et al.
BREAST CANCER (2016)
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer
Young Kwang Chae et al.
PLOS ONE (2016)
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
Andrew McGuire et al.
CANCER AND METASTASIS REVIEWS (2015)
A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer
S. Cowherd et al.
CANCER BIOLOGY & THERAPY (2015)
Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment
Todd VanArsdale et al.
CLINICAL CANCER RESEARCH (2015)
ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment
Sixiang Shi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer
Simone U. Dalm et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Mechanisms involved in breast cancer liver metastasis
Rui Ma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles
Hamidreza Zolata et al.
NUCLEAR MEDICINE AND BIOLOGY (2015)
Comparative evaluation of 111In-labeled NOTA-conjugated affibody molecules for visualization of HER3 expression in malignant tumors
Ken G. Andersson et al.
ONCOLOGY REPORTS (2015)
BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy
Katerina Bouchalova et al.
TUMOR BIOLOGY (2015)
Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances
Jasmine M. Miller-Kleinhenz et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
CXCR4 in breast cancer: oncogenic role and therapeutic targeting
Chao Xu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Folate Receptor α Associated With Triple-Negative Breast Cancer and Poor Prognosis
Zhang Zhang et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
Zhigang Zhang et al.
BMC CANCER (2014)
Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid Tumors
Toshio Shimizu et al.
CLINICAL CANCER RESEARCH (2014)
Interactions between Anticancer trans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts of trans-(Dimethylamino)(methylamino)dichloridoplatinum(II)
Luigi Messori et al.
INORGANIC CHEMISTRY (2014)
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Jonathan E. Rosenberg et al.
INVESTIGATIONAL NEW DRUGS (2014)
The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a 68Ga-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin
Zohreh Varasteh et al.
MOLECULES (2014)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Cellular uptake of cobalamin: Transcobalamin and the TCblR/CD320 receptor
Edward V. Quadros et al.
BIOCHIMIE (2013)
Phase I Study of U3-1287, a Fully Human Anti-HER3 Monoclonal Antibody, in Patients with Advanced Solid Tumors
Patricia LoRusso et al.
CLINICAL CANCER RESEARCH (2013)
MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer
Alan Siroy et al.
HUMAN PATHOLOGY (2013)
Navigating the B12 Road: Assimilation, Delivery, and Disorders of Cobalamin
Carmen Gherasim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
VPAC1 Receptors for Imaging Breast Cancer: A Feasibility Study
Mathew L. Thakur et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Novel 64Cu-Labeled CUDC-101 for in Vivo PET Imaging of Histone Deacetylases
Qingqing Meng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
Dai Horiuchi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Dual targeting strategies with bispecific antibodies
Roland E. Kontermann
MABS (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Annotating MYC status with 89Zr-transferrin imaging
Jason P. Holland et al.
NATURE MEDICINE (2012)
Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients
Irena Ranogajec et al.
MEDICAL ONCOLOGY (2012)
Integrins as therapeutic targets
Simon L. Goodman et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin
Bart Cornelissen et al.
EJNMMI RESEARCH (2012)
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
Chandra R. Tate et al.
BREAST CANCER RESEARCH (2012)
Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer
Nuhad K. Ibrahim et al.
CLINICAL CANCER RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Clinical radioimmunotherapy-the role of radiobiology
Jean-Pierre Pouget et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance
Rajiv Dua et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Antitumor Effects and Normal-Tissue Toxicity of 111In-Nuclear Localization Sequence-Trastuzumab in Athymic Mice Bearing HER-Positive Human Breast Cancer Xenografts
Danny L. Costantini et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Molecular Imaging of MDM2 Messenger RNA with 99mTc-Labeled Antisense Oligonucleotides in Experimental Human Breast Cancer Xenografts
Peng Fu et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Tissue factor in cancer progression and angiogenesis
Wolfram Ruf et al.
THROMBOSIS RESEARCH (2010)
The coordination chemistry of 1,4,7,10-tetraazacyclododecane-N,N′,N,N′′′-tetraacetic acid (H4DOTA): Structural overview and analyses on structure-stability relationships
Nerissa Viola-Villegas et al.
COORDINATION CHEMISTRY REVIEWS (2009)
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
Jeffrey S. Ross et al.
ONCOLOGIST (2009)
International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
R. T. Jensen et al.
PHARMACOLOGICAL REVIEWS (2008)
P-glycoprotein and breast cancer resistance protein: Two dominant transporters working together in limiting the brain penetration of topotecan
Nienke A. de Vries et al.
CLINICAL CANCER RESEARCH (2007)
Targeted cancer therapy with a novel low-dose rate α-emitting radioimmunoconjugate
Jostein Dahle et al.
BLOOD (2007)
Enhanced tumor cell kill by combined treatment with a small-molecule antagonist of mouse double minute 2 and adenoviruses encoding p53
Harm C. A. Graat et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The blood-brain barrier and cancer:: Transporters, treatment, and Trojan horses
John F. Deeken et al.
CLINICAL CANCER RESEARCH (2007)
Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced Von Hippel-Lindau disease of the retina
Sam S. Dahr et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2007)
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Natalia V. Sergina et al.
NATURE (2007)
Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the auger electron-emitting radiopharmaceutical In-111-DTPA-human epidermal growth factor
Kristy E. Bailey et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Discovery and development of anticancer aptamers
Christopher R. Ireson et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The role of CXCR4 receptor expression in breast cancer:: a large tissue microarray study
Ombretta Salvucci et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis
KA O'Donnell et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]
Vasso Apostolopoulos et al.
BREAST CANCER RESEARCH (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Oncogenic PI3K deregulates transcription and translation
AG Bader et al.
NATURE REVIEWS CANCER (2005)
Expression of sigma 1 receptor in human breast cancer
B Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells
M Rolli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma
M Kato et al.
BREAST CANCER RESEARCH (2003)
Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting
JC Reubi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide:: The Rotterdam experience
R Valkema et al.
SEMINARS IN NUCLEAR MEDICINE (2002)
Share Paper
